STOCK TITAN

Nano Labs Ltd SEC Filings

NA NASDAQ

Welcome to our dedicated page for Nano Labs SEC filings (Ticker: NA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Nano Labs Ltd filings document its foreign private issuer current reports on Form 6-K, including press releases incorporated by reference into registration statements. These records cover financial results, cryptocurrency holdings and fair-value changes, product announcements for iPollo and OpenClaw, and strategic initiatives tied to Web 3.0 infrastructure.

The filings also record capital and governance matters, including share repurchase activity, annual general meeting proposals, amendments to the memorandum and articles of association, Class B ordinary share voting rights and the appointment of an independent registered public accounting firm.

Rhea-AI Summary

Nano Labs Ltd, a foreign private issuer based in Hangzhou, China, furnished a Form 6-K for November 2025. The filing does not present new financial results but focuses on a legal and disclosure update.

The company attaches a press release as Exhibit 99.1 and formally incorporates this document by reference into four existing registration statements on Form F-3 and a post-effective amendment to a Form F-1 on Form F-3. From the date of this report, that press release becomes part of those registration statements unless later filings supersede it. The report is signed by Chairman and Chief Executive Officer Jianping Kong.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.99%
Tags
current report
-
Rhea-AI Summary

Nano Labs Ltd filed a Form 6-K to furnish a press release as Exhibit 99.1 and formally incorporate that document into several existing registration statements on Form F-3 and a post-effective amendment to Form F-1. This step ensures the press release is legally part of those shelf registration materials for U.S. investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
current report
-
Rhea-AI Summary

Nano Labs Ltd filed a Form 6-K as a foreign private issuer for September 2025. The filing furnishes unaudited consolidated financial statements as of December 31, 2024 and June 30, 2025, along with results for the six months ended June 30, 2024 and 2025.

The 6-K also includes management’s discussion and analysis of financial condition and results of operations, and incorporates these materials by reference into three existing Form F-3 registration statements previously filed with the U.S. Securities and Exchange Commission.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Nano Labs Ltd Schedule 13D Amendment No.5 reports that Wlyl Ltd purchased 480,000 Class A ordinary shares in open-market transactions from August 21 to August 25, 2025 for investment purposes. As of August 25, 2025 the reporting persons collectively beneficially own 4,918,545 ordinary shares, which the filing states represents 20.9% of the outstanding ordinary shares on a converted-basis (23,571,833 shares). NLABS FUND PTE LTD. directly holds 1,888,342 Class A shares (8.0%), NlabsDAO Trust/JIANPING KONG LTD holds 2,370,391 shares (10.1%), and Wlyl Ltd/Lunyu Trust holds 659,812 shares (2.8%). The filing explains the two-class capital structure where each Class B share converts into one Class A and carries 30 votes per Class B share, creating pronounced voting leverage for Class B holders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Nano Labs Ltd Schedule 13D Amendment No.5 reports that Wlyl Ltd purchased 480,000 Class A ordinary shares in open-market transactions from August 21 to August 25, 2025 for investment purposes. As of August 25, 2025 the reporting persons collectively beneficially own 4,918,545 ordinary shares, which the filing states represents 20.9% of the outstanding ordinary shares on a converted-basis (23,571,833 shares). NLABS FUND PTE LTD. directly holds 1,888,342 Class A shares (8.0%), NlabsDAO Trust/JIANPING KONG LTD holds 2,370,391 shares (10.1%), and Wlyl Ltd/Lunyu Trust holds 659,812 shares (2.8%). The filing explains the two-class capital structure where each Class B share converts into one Class A and carries 30 votes per Class B share, creating pronounced voting leverage for Class B holders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Nano Labs Ltd furnished a Form 6-K to provide a press release, attached as Exhibit 99.1, and to formally incorporate that exhibit by reference into its two effective shelf registration statements on Form F-3. This means the press release is now legally part of those registration statements for U.S. securities law purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
current report
Rhea-AI Summary

Nano Labs Ltd furnished a Form 6-K as a foreign private issuer, providing additional information to U.S. investors. The company states that the document attached as Exhibit 99.1 is incorporated by reference into its existing shelf registration statements on Form F-3, one initially filed on August 14, 2023 and another initially filed on August 4, 2025, so that this material becomes part of those offerings unless later superseded. The filing also lists a press release as Exhibit 99.1 and a sales agreement as Exhibit 99.2, indicating these materials are now formally on record with U.S. regulators.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
current report
-
Rhea-AI Summary

Nano Labs Ltd files a prospectus supplement for an "at-the-market" offering of up to 10,000,000 Class A ordinary shares for aggregate proceeds up to US$45,000,000 at an assumed price of $4.50 per share (last reported Nasdaq sale on August 20, 2025). Before the offering the company had 23,571,833 ordinary shares outstanding (20,712,924 Class A and 2,858,909 Class B); after the offering up to 33,571,833 ordinary shares assuming full sale. Net tangible book value per share was presented as $3.46 and as-adjusted $3.73, with a decrease to new investors of $0.77. The company intends to use proceeds for a BNB and crypto asset reserve strategy, R&D and general corporate purposes. The supplement incorporates extensive risk disclosures highlighting cryptocurrency market volatility, regulatory and PRC-specific risks, supplier concentration, potential PCAOB inspection/delisting risk, dual-class share structure and other corporate governance and operational risks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
prospectus
-
Rhea-AI Summary

Nano Labs Ltd furnished a Form 6-K as a foreign private issuer in August 2025. The filing attaches a press release as Exhibit 99.1 and formally incorporates that document by reference into two existing Form F-3 shelf registration statements, originally filed on August 14, 2023 and August 4, 2025. This makes the press release part of those registration statements for U.S. securities law purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.78%
Tags
current report

FAQ

How many Nano Labs (NA) SEC filings are available on StockTitan?

StockTitan tracks 56 SEC filings for Nano Labs (NA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Nano Labs (NA)?

The most recent SEC filing for Nano Labs (NA) was filed on November 12, 2025.